Table 3.
Characteristics of patient’s apheresis
| Spectra Optia | Fresenius Com.Tec | p value | |
|---|---|---|---|
| WBC × 103/µL | 18.85 (1.7–82.3) | 21.2 (2.1–63.0) | p = 0.37 |
| PLT × 103/µL | 90.5 (16–229) | 107 (33–300) | p = 0.08 |
| Procedure time (min) | 227 (136–358) | 174 (112–259) | p = 0.001 |
| Number of apheresis per case | 2.3 (1–5) | 2.3 (1–4) | p = 0.63 |
| ACD used (mL) | 806 (336–1630) | 580 (319–925) | p = 0.001 |
| Total blood volume (mL) | 2.1 (1.3–4.8) | 4.2 (2–5.2) | p = 0.001 |
| Product volume (mL) | 177 (28–360) | 220 (40–330) | p = 0.001 |
| Processed blood volume (L) | 11,002 (3697–101,269) | 7717 (4715–12,015) | p = 0.07 |
| Peripheral CD34+ cell count (µL) | 46.68 (1.2–356) | 49 (4.2–142) | p = 0.77 |
| CD34+ cell count in Product (µL) | 1627 (32–8207) | 1155 (0.2–6474) | p = 0.018 |
| CD34+ cells infused (106/kg) | 3.69 (0.1–26.1) | 3.3 (0.2–19.4) | p = 0.58 |
| Product WBC × 103/µL | 280 (60–500) | 212 (60–570) | p = 0.02 |
| Product Hct % | 0.58% (0.1–2%) | 1.17% (0.1–3%) | p = 0.001 |
| CD34+ collection efficiency 2 (CE2) % | 89% (6–390%) | 71% (3–200%) | p = 0.07 |